Mounjaro · Starting out
Your first week on Mounjaro
Published by MALAI · Last updated
Week one is 2.5 mg. Unlike semaglutide's 0.25 mg start, tirzepatide's opening dose is already doing something — and because it acts on GIP receptors as well as GLP-1, appetite suppression tends to arrive faster and harder than people expect from week one.
What happens, day by day
Day 1
Inject. Many people notice a drop in appetite within the first several hours, which is earlier than the semaglutide drugs typically produce.
Days 1–3
Gastrointestinal effects peak here if they appear. The label reports nausea in 12% of patients on 5 mg rising to 18% on 15 mg, against 4% on placebo — markedly lower than semaglutide's rates, which is the usual reason people tolerate tirzepatide better.
Days 4–7
Food noise quietens noticeably. The risk in week one on tirzepatide is under-eating rather than over-eating: appetite can drop far enough that protein falls without you noticing.
End of week 1
Some early loss is common, and most of it is water. Judge week one on whether you hit protein, not on the scale.
Where 2.5 mg sits in the ladder
2.5 mg → 5 → 7.5 → 10 → 12.5 → 15 mg, six steps across sixteen weeks — the longest ladder here. By week 4 you are still on 2.5 mg or moving to 5 mg. The starting dose is officially a non-therapeutic lead-in, though most people feel it clearly.
What to eat in week one
Tirzepatide moves faster than semaglutide does. Peak concentration arrives at a median of 24 hours after your dose, with a range of 8 to 72 (prescribing information, section 12.3), so it is the day after your shot you want to plan around rather than the day itself. There is a second thing week one on Mounjaro asks of you that the weight-loss drugs do not. You are almost certainly still taking your other diabetes medications at their existing doses while your appetite drops away underneath them. Eating far less on an unchanged sulfonylurea or insulin dose is how first-week hypoglycaemia happens, and it is the most avoidable problem on this page. Keep meals regular even on the days you do not want them, aim for 1.4 to 1.6 g of protein per kg, and tell your prescriber how much less you are eating — the label anticipates that those other doses may need reducing (section 5.3).
What Mounjaro is licensed for — and why that matters now
Mounjaro is approved for type 2 diabetes, in 2022. Using it for weight management is off-label, which is the single most consequential fact about being on it for that reason: insurers generally will not cover tirzepatide for weight under the Mounjaro label. Zepbound is the identical molecule on the identical ladder, licensed for weight management — so if weight is why you are here, week one is the right time to ask whether you should be on that instead. Clinically you would be changing nothing.
First week on Zepbound — the same tirzepatide, licensed differently →
What is normal, and what is worth a call
Nausea and loose stools in the first days are expected and usually settle. Call your prescriber for vomiting that prevents fluids, severe abdominal pain, or if you have a personal or family history of medullary thyroid carcinoma that was not discussed before prescribing.
First week on the other GLP-1s:
Frequently asked questions
- Is Mounjaro's 2.5 mg starting dose supposed to do anything?
- Officially it is a lead-in for tolerance, not a therapeutic dose — but most people feel it. Tirzepatide acts on GIP receptors as well as GLP-1, and that dual action produces noticeable appetite suppression earlier than semaglutide's 0.25 mg start does. Expect the effect to be real even though the label treats the dose as preparatory.
- Should I be on Zepbound instead of Mounjaro for weight loss?
- It is worth asking in week one. They are the same molecule, tirzepatide, on the same six-step ladder from 2.5 mg to 15 mg. Mounjaro is licensed for type 2 diabetes and Zepbound for chronic weight management, so if weight is the reason for the prescription, Zepbound is the on-label route and the one insurance can actually be asked to cover. Clinically the switch changes nothing.
- Will my blood sugar drop too low in the first week on Mounjaro?
- On Mounjaro by itself, unlikely. Alongside a sulfonylurea or insulin it is a genuine week-one risk, and the label says so: used with an insulin secretagogue or insulin, Mounjaro may increase the risk of hypoglycemia including severe hypoglycemia, and reducing the dose of that other medication may be necessary (prescribing information, section 5.3). Week one is the exposed moment because your appetite changes immediately and your other prescriptions do not. Test more often for a fortnight, and tell your prescriber how much less you are eating.
- Why do I have sulfur burps on Mounjaro?
- Because your stomach is emptying more slowly and food sits there longer than it used to. Mounjaro logged eructation, or belching, in about 3% of patients against 0.4% on placebo (prescribing information, section 6.1), and the rotten-egg smell comes from sulphur-containing protein fermenting during that longer wait. Unpleasant, not dangerous. Portion size is the main trigger, so smaller meals help most, and easing off very large servings of meat helps too. Spreading the same protein across four meals usually settles it without costing you a gram.
- Does decreased appetite start in the first week on Mounjaro?
- Very common on Mounjaro overall. Reported by 5% on 5mg rising to 11% on 15mg against 1% on placebo in the prescribing information. It is the intended effect rather than a complication, but it is also why protein needs deliberate planning on tirzepatide. In week one you are on 2.5 mg, below the doses those figures come from, so if it turns up at all it is usually milder than the label rate suggests.